Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04963764 · ClinicalTrials.gov registry record · Early Phase 1
Procalcitonin to Reduce Antibiotic Use in Pediatric Pneumonia
A Early Phase 1 study of Pneumonia and Community-acquired Pneumonia, sponsored by Ann & Robert H Lurie Children's Hospital of Chicago.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 5
- Enrollment target
- 3
- Study locations
NCT04963764 is a Early Phase 1 study of Pneumonia and Community-acquired Pneumonia that has completed, run by Ann & Robert H Lurie Children's Hospital of Chicago. The registered enrollment target is 5 participants, below the 4,519-participant average among 47 other Pneumonia trials with a reported enrollment target (100% lower). The trial reports 3 study locations across 3 states.
The verdict
NCT04963764, a Early Phase 1 study of Pneumonia and Community-acquired Pneumonia, has completed, sponsored by Ann & Robert H Lurie Children's Hospital of Chicago.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 5 participants
- Enrollment target
- 3
- Study locations
Study Summary
This pilot study will evaluate study processes and feasibility of a future large-scale clinical trial that proposes to test whether low-risk children managed as outpatients with community-acquired pneumonia (CAP) and procalcitonin (PCT) levels \<0.25 ng/mL treated with placebo have a similar clinical response to those treated with antibiotics and fewer adverse effects.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Amoxicillin
Study Locations (3)
Illinois
- Ann & Robert H Lurie Children's Hospital of Chicago - Chicago
Ohio
- Cincinnati Children's Hospital Medical Center - Cincinnati
Pennsylvania
- The Children's Hospital of Philadelphia - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2021-10-18 |
| Est. Completion | 2022-05-27 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04963764
The ClinicalTrials.gov registry entry for NCT04963764 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,519-participant average among 47 other Pneumonia trials with a reported enrollment target (100% lower). The listed sponsor is Ann & Robert H Lurie Children's Hospital of Chicago, which has 159 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Pneumonia appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT04963764 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Illinois, Ohio, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT04963764 about?
NCT04963764 is a clinical study titled "Procalcitonin to Reduce Antibiotic Use in Pediatric Pneumonia". This pilot study will evaluate study processes and feasibility of a future large-scale clinical trial that proposes to test whether low-risk children managed as outpatients with community-acquired pneumonia (CAP) and procalcitonin (PCT) levels \<0.25 ng/mL treated with placebo have a similar clinica...
What is the current status of trial NCT04963764?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 5 participants. The study started on 2021-10-18. Estimated completion is 2022-05-27.
What conditions does trial NCT04963764 study?
This clinical trial studies the following conditions: Pneumonia, Community-acquired Pneumonia, Pediatric Respiratory Diseases, Antibiotic Use.
What interventions are being tested in trial NCT04963764?
The interventions under investigation include: Placebo (DRUG), Amoxicillin (DRUG).
Who is sponsoring clinical trial NCT04963764?
This trial is sponsored by Ann & Robert H Lurie Children's Hospital of Chicago, which has 159 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04963764 being conducted?
This trial has 3 study locations across Illinois, Ohio, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pneumonia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
iNO300 Therapy in Critically Ill Patients With Pneumonia
RECRUITING · Early Phase 1
-
The APS Phenotyping Study
RECRUITING
-
Reducing Overuse of Antibiotics With Decision Support
RECRUITING · NA
-
Extending Dental Care to Nursing Home Residents to Reduce Mouth Infections and Incidence of Pneumonia and Improve Diabetic Glucose Control
RECRUITING · NA
-
Clinical Utility of Portable Dynamic Chest X Ray (DDR) in the ICU
RECRUITING · NA
-
A Study to Learn About How 20-Valent Pneumococcal Conjugate Vaccine Works in a Real-world Setting
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.